Atlas Trials

MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer

Clinical trial NCT04082182 · UNKNOWN

Trial details

NCT number
NCT04082182
Sponsor
University Hospital, Ghent
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer Metastatic
Start date
2019-08-26
Primary completion
2021-06-07
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.